[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2014 Sales of Recombinant Therapeutic Antibodies & Proteins

March 2015 | 39 pages | ID: 23D6C7666CAEN
La Merie Publishing

US$ 140.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
2014 Sales of Recombinant Therapeutic Antibodies & Proteins

This Competitive Intelligence report prepared by La Merie Business Intelligence provides a compilation of the sales data of recombinant therapeutic proteins and antibodies in the calendar year 2014. Sales data were obtained from company publications and refer to branded products originating from companies based in regulated markets. All sales data were converted from their original, published currency into US$ using official currency exchange rates as of March 17, 2015. Sales figures represent the sum of revenues in all territories where the products are marketed and are mostly presented either after hedging.

Sales data are presented for each product within the respective class of biologics. The data were analyzed to establish a ranking list of blockbuster biologics with 2014 sales higher than US$ 1 bln. Another ranking list was prepared for companies according to biologics sales in 2014 and the percentage of antibody sales vs protein sales.
2014 BIOLOGICS SALES PER CLASS OF PRODUCTS
Blockbuster Biologics in 2014 (by generic name)
Company Ranking List for Biologics Sales 2014
Biologic Product Sales 2014
  Anti-TNF Antibodies
  Cancer Antibodies
  Insulin and Insulin Analogs
  Anti-Inflammatory and Anti-Autoimmune Antibodies
  Recombinant Coagulation Factors
  Ophthalmic Antibodies
  Erythropoietins
  Interferon beta
  G-CSF
  Enzyme Replacement Proteins
  Human Growth Hormone
  Interferon alpha
  Follicle Stimulating Hormone
  Cardiometabolic & Anti-Infective Antibodies
  Other Proteins: Cardiometabolic, Cancer & Others


More Publications